PodcastOne (NASDAQ: PODC) Reports Record Q1 Fiscal 2026 Financial Results

PodcastOne (NASDAQ: PODC) Reports Record Q1 Fiscal 2026 Financial Results GlobeNewswire August 13, 2025 Q1 Fiscal 2026 Revenue: ~$15.0 Million (Record) Q1 Fiscal 2026 Adjusted EBITDA*: ~$0.6 Million Fiscal 2026 Guidance: Revenue: $55-60 Million, Adjusted EBITDA*: $3-5 Million LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) — PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales […]

Integral Metals Announces Private Placement Offering

Integral Metals Announces Private Placement Offering GlobeNewswire August 13, 2025 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) — Integral Metals Corp. (CSE: INTG | FSE: ZK9) (the “Company“ or “Integral“) is pleased to announce that it intends to complete

The Marquie Group Provides Update on Year-End Audit and Launch of New Website

The Marquie Group Provides Update on Year-End Audit and Launch of New Website GlobeNewswire August 13, 2025 DALLAS, Aug. 13, 2025 (GLOBE NEWSWIRE) — The Marquie Group, Inc. (OTCID:TMGI) (the “Company”) today announced that its year-end audit and preparation of its Annual Report on Form 10-K are underway. The Company expects to file the Form

Guident Announces Autonomous Shuttle Transportation Service in Boca Raton, Florida

Guident Announces Autonomous Shuttle Transportation Service in Boca Raton, Florida GlobeNewswire August 13, 2025 Guident Corp.'s MiCa Pictured in Downtown Boca Raton Boca Raton, FL, Aug. 13, 2025 (GLOBE NEWSWIRE) — Guident Corp. (“Guident”), an autonomous vehicle (AV) teleoperation company headquartered in Boca Raton, FL, announces an agreement with the City of Boca Raton, Florida,

Cemtrex Highlights $1.3 Million in Notable New Contracts in Past Week Across Security and Industrial Divisions, Reinforces FY26 Growth Outlook

Cemtrex Highlights $1.3 Million in Notable New Contracts in Past Week Across Security and Industrial Divisions, Reinforces FY26 Growth Outlook GlobeNewswire August 13, 2025 Hauppauge, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) — Cemtrex Inc. (Nasdaq: CETX), a technology company driving innovation in intelligent security and industrial services, today announced a series of notable new contract

Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update Company Initiates Combination Trial and Strengthens Balance Sheet to Support Continued Clinical Progress GlobeNewswire August 13, 2025 NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative

LiqTech International Announces Second Quarter 2025 Financial Results

LiqTech International Announces Second Quarter 2025 Financial Results GlobeNewswire August 13, 2025 BALLERUP, Denmark, Aug. 13, 2025 (GLOBE NEWSWIRE) — LiqTech International, Inc. (Nasdaq: LIQT) (“LiqTech”), a clean technology company that manufactures and markets highly specialized filtration technologies, today announced its financial results for the second quarter of 2025 for the period ended June 30,

Gabelli Funds to Host 31st Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 4, 2025

Gabelli Funds to Host 31st Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 4, 2025 GlobeNewswire August 13, 2025 GREENWICH, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC, is hosting our annual Aerospace & Defense Symposium at The Harvard Club in New York City on September 4th.

Refold AI emerges from stealth with $6.5M to kill the enterprise “integration tax”

Refold AI emerges from stealth with $6.5M to kill the enterprise “integration tax” Every year enterprises pay $350B to big consultancies and systems integrators to ensure API's work smoothly. Refold AI to end this tax on business with a platform that removes API complexity into repeatable, productized software with AI. GlobeNewswire August 13, 2025 San

CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study

CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study GlobeNewswire August 13, 2025 – The CTMX-2051-101 study has enrolled 73 colorectal cancer patients to-date, aligned with the Company's goal of providing a Phase 1 data update in Q1 2026 – – The CTMX-2051-101 study remains active and patients continue to be dosed with CX-2051 across

Scroll to Top